Close Menu

NEW YORK – Biocept reported after the close of the market on Wednesday that its third quarter revenues nearly doubled year over year on strong growth in the number of commercial samples received.

For the three months ended Sept. 30, the San Diego-based company posted $1.5 million in revenues compared to $761,591 in Q3 2018.The number of commercial samples received in the recently completed quarter grew 66 percent year over year, it said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.